Y mAbs Therapeutics
Biotechnology
Healthcare
YMAB
45.10 M shares
NASDAQ US
traded
15 Sep 2025
listed
no
open
8.59
52 week high
15.69
high
8.61
52 week low
0.00
low
8.59
growth
-37.29 %
previous Close
8.59
P/E ratio
market cap
195 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
100.00 %
net profit margin
0.00 %
24.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top